(Q36186740)

12 August 2017

1 reference

title

Evidence that immunoglobulin-positive neurons in Alzheimer's disease are dying via the classical antibody-dependent complement pathway (English)

1 reference

12 August 2017

0 references

Michael R D'Andrea

1

1 reference

PubMed ID

16003929

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

American Journal of Alzheimer's Disease & Other Dementias

12 August 2017

1 reference

12 August 2017

20

1 reference

12 August 2017

3

1 reference

12 August 2017

144-150

1 reference

Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease.

12 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Add Alzheimer's disease to the list of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Early complement activation increases in the brain in some aged normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Complement activation by neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Complement biosynthesis in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Complement component C1q modulates the phagocytosis of Abeta by microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

The microglial phagocytic role with specific plaque types in the Alzheimer disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000303

10.1177/153331750502000303

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16003929